- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 절제 불가능한 간세포 암종 in Hong Kong
총 390 건
-
The University of Hong Kong완전한
-
Humanity & Health Medical Group Limited모병
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of Medicine종료됨
-
Aegera TherapeuticsChinese University of Hong Kong완전한
-
The University of Hong Kong알려지지 않은
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong완전한
-
Chinese University of Hong KongHealth and Medicine Research Fund모병
-
Chinese University of Hong KongThe Hong Kong Society of Gastroenterology완전한
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong완전한
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong완전한
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong완전한
-
The University of Hong KongQueen Mary Hospital, Hong Kong모병
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong완전한
-
The University of Hong Kong알려지지 않은
-
Zai Lab (Shanghai) Co., Ltd.종료됨
-
Chinese University of Hong Kong모병
-
Chinese University of Hong Kong완전한
-
Chinese University of Hong Kong아직 모집하지 않음
-
Omega Therapeutics모병간세포 암 | 고형종양 | 간 암 | 절제 불가능한 간세포 암종 | 간세포암 | 재발성 간세포 암종 | 간암, 절제 불가능미국, 홍콩, 대한민국, 싱가포르, 대만
-
Chinese University of Hong Kong모집하지 않고 적극적으로EUS 가이드 시아노아크릴레이트 주입 | 내시경 정맥류 밴드 결찰술 | 간세포 암종 | 식도 정맥류 출혈홍콩
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong종료됨
-
The University of Hong KongQueen Mary Hospital, Hong Kong모병
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong; Queen Mary... 그리고 다른 협력자들모집하지 않고 적극적으로
-
Hospital Authority, Hong KongSchering-Plough알려지지 않은
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany완전한
-
Humanity & Health Medical Group LimitedTokyo University모병
-
Dr Joanne CHIU모병ALK 유전자 재배열 양성 | EGF-R 양성 비소세포폐암 | EGFR 활성화 돌연변이 | Nsclc | ROS1 유전자 재배열 | ROS1 양성 NSCLC - 반응성 산소종 1 양성 비소세포폐암홍콩
-
Chinese University of Hong Kong모병